May 12 (Reuters) -
* Russian pharmaceutical firm R-Pharm will in June start
the first doses in Russia of the COVID-19 vaccine developed by
AstraZeneca and Oxford University, RBC magazine reported
on Wednesday, citing the company's director Vasiliy Ignatiev.
* It will produce a few hundred thousand doses a month, RBC
Ignatiev as saying.
* The company will be making doses exclusively for export,
use in Russia, RBC reported. It will handle exports together
with the Russian Direct Investment Fund, the sovereign wealth
fund responsible for marketing the Russian-made Sputnik V
-- Source link: https://www.rbc.ru/business/12/05/2021/609be9e09a794724e9305084?from=from_main_6
-- Note: Reuters has not verified this story and does not vouch
for its accuracy.
(Reporting by Moscow newsroom; editing by Philippa Fletcher)